文献速递皮肤肿瘤

基底细胞癌、鳞状细胞癌及原位鳞癌患者的生存:全人群研究

Survival of patients with basal cell carcinoma, squamous cell carcinoma, and squamous cell carcinoma in situ: A whole population study.
PubMed 文献 · J Am Acad Dermatol · 2023-09-26

该全人群研究基于冰岛癌症登记库1981–2015年数据,纳入8767例首次诊断局限性角化细胞癌患者,分析基底细胞癌(BCC)、鳞状细胞癌(SCC)及原位鳞癌(SCCis)对生存的影响。结果显示BCC总体上不降低相对生存,但1981–1995年诊断的男性BCC患者10年相对生存降低(85.3,95%CI 77.9-92.7);SCC和SCCis在部分亚组(如诊断时<50岁)与相对生存降低相关。

要点

  • BCC总体上与相对生存降低无关,但1981–1995年诊断的男性BCC患者10年相对生存降低(85.3,95%CI 77.9-92.7)。
  • SCC和SCCis在部分人群亚组(如诊断时<50岁)与相对生存降低相关。
  • 该全人群研究支持既往研究结论:BCC不降低相对生存,SCC和SCCis在特定亚组相对生存较差。

核心结论

  • BCC总体上与相对生存降低无关,但1981–1995年诊断的男性BCC患者10年相对生存降低(85.3,95%CI 77.9-92.7)。
  • SCC和SCCis在部分人群亚组(如诊断时<50岁)与相对生存降低相关。

研究设计与样本

  • 全人群队列生存研究,使用冰岛癌症登记库1981–2015年所有BCC、SCCis和SCC记录。
  • 共纳入8767例首次诊断局限性角化细胞癌的冰岛人,其中BCC 6473例、SCCis 1194例、侵袭性SCC 1100例。

主要发现

  • BCC总体上未显示与相对生存降低相关,但1981–1995年诊断的男性BCC患者10年相对生存降低(85.3,95%CI 77.9-92.7)。
  • SCC和SCCis在部分人群亚组(如诊断时<50岁)与相对生存降低相关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Keratinocyte carcinoma (KC) is the commonest type of malignancy in humans; however, the impact of KC on survival is poorly understood. OBJECTIVES: This study characterizes the impact of basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and squamous cell carcinoma in situ (SCCis) on the survival of Icelanders. METHODS: This whole population study evaluated relative survival of KC in Iceland by using a cancer registry containing records of all BCC, SCCis, and SCC cases recorded in Iceland between 1981 and 2015. RESULTS: Between 1981 and 2015, 8767 Icelanders were diagnosed with their first localized KC. A total of 6473 individuals with BCC, 1194 with SCCis, and 1100 with invasive SCC, respectively. BCC was not associated with decreased survival except for men diagnosed with BCC between 1981 and 1995 for whom decreased 10-year relative survival was observed (85.3, 95% CI [77.9-92.7]). SCC and SCCis were both associated with a decrease in relative survival for certain population subgroups such as individuals <50 years of age at time of diagnosis. CONCLUSION: Our whole population cohort survival study examining the Icelandic Cancer Registry supports prior studies demonstrating that BCC is not associated with a reduction in relative survival and that SCC and SCCis are associated with comparatively poor relative survival in certain population subgroups.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Sharp K, Olafsdottir EJ, Sahni DR, et al. Survival of patients with basal cell carcinoma, squamous cell carcinoma, and squamous cell carcinoma in situ: A whole population study. J Am Acad Dermatol. 2023. PMID: 37758026. doi:10.1016/j.jaad.2023.09.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。